Table 5.
Variables | Level | HR (95% CI) | p |
---|---|---|---|
Gender (ref = Male) | Female | 0.81 (0.28–2.40) | 0.709 |
Race (ref = White) | Others | 1.77 (0.37–8.41) | 0.476 |
PS ECOG (ref=0–1) | ≥ 2 | 0.73 (0.16–3.30) | 0.680 |
Histology Differentiation (ref = Well/Moderate) | Poorly differentiation | 4.60 (1.20–17.59) | 0.026 |
Liver metastasis (ref = No) | Yes | 1.22 (0.39–3.85) | 0.729 |
Peritoneum metastasis (ref = No) | Yes | 0.69 (0.09–5.39) | 0.722 |
Lung metastasis (ref = No) | Yes | 0.99 (0.31–3.11) | 0.981 |
Prior Operation (ref = No) | Yes | 0.94 (0.33–2.69) | 0.902 |
Max2, per 1SD (SD = 0.046) increase | Female | 1.19 (0.80–1.77) | 0.405 |
Age at Diagnosis, per 5 years old increase | 1.02 (0.70–1.48) | 0.932 | |
CIRS-G severity index | 1.25 (0.65–2.38) | 0.505 | |
Number of CIRS-G score 3 (ref=0) | 1 | 2.23 (0.59–8.37) | 0.236 |
>=2 | 1.34 (0.35–5.10) | 0.664 | |
Number of CIRS-G score 4 (ref=0) | >=1 | 0.00 (0.00-.) | 0.995 |
HEART (ref=0) | 1–4 | 0.63 (0.08–4.99) | 0.665 |
VASCULAR (ref=0) | 1–4 | 0.32 (0.10–1.01) | 0.051 |
HEMATOPOIETIC (ref=0) | 1–4 | NA | NA |
RESPIRATORY (ref=0) | 1–4 | 3.13 (1.10–8.88) | 0.032 |
EENT_LARYNX (ref=0) | 1–4 | 1.24 (0.45–3.47) | 0.676 |
UPPER_GI (ref=0) | 1–4 | 1.08 (0.34–3.44) | 0.901 |
LOWER_GI (ref=0) | 1–4 | 1.91 (0.60–6.06) | 0.271 |
LIVER (ref=0) | 1–4 | NA | NA |
RENAL (ref=0) | 1–4 | 4.91 (1.34–17.91) | 0.016 |
GENITOURINARY (ref=0) | 1–4 | 0.93 (0.31–2.75) | 0.893 |
MUSCULOSKELETAL (ref=0) | 1–4 | 0.84 (0.30–2.36) | 0.737 |
NEUROLOGICAL (ref=0) | 1–4 | 1.39 (0.18–11.02) | 0.756 |
ENDOCRINE (ref=0) | 1–4 | 1.57 (0.46–5.34) | 0.468 |
PSYCHIATRIC_ILLNESS (ref=0) Total Risk Score (ref 0–1) |
1–4 >=2 |
1.35 (0.29–6.27) 4.32 (1.32–14.12) |
0.704 0.015 |
(b) | |||
---|---|---|---|
Variables | Level | HR (95% CI) | p |
Histology Differentiation (ref = Well/Moderate) | Poorly differentiation | 14.63 (2.63, 81.56) | 0.002 |
Total risk score | >=2 | 7.49 (1.81, 31.09) | 0.006 |